value to emerging growth companies

8
Brain Cancer Breast Cancer Cervical Cancer Chronic Lymphocytic Leukemia Endometrial Cancer Ewing Sarcoma Gastric Cancer Gastrointestinal Stromal Tumors Head And Neck Cancer Hodgkin Lymphoma Kidney Cancer Liver Cancer Malignant Mesothelioma Medullary Thyroid Cancer Melanoma Multiple Myeloma Non-Hodgkin Lymphoma Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Testicular Cancer Thyroid Cancer Age Related Macular Degeneration Keratoconjunctivitis sicca (Dry Eye) Retinal Vein Occlusion Acute Respiratory Distress Syndrome Sepsis Staphylococcal Infections Acute Coronary Syndrome Angina Pectoris Atrial Fibrillation Coronary Artery Disease (CAD) Critical Limb Ischemia Hypertension Pulmonary Arterial Hypertension Acute Pain Anxiety Disorders Chronic Pain Dementia Diabetic Neuropathy Obsessive-Compulsive Disorder Osteoarthritis Pain Parkinson's Disease Post-Traumatic Stress Disorder Restless Legs Syndrome Schizophrenia Traumatic Brain Injury Liver Cirrhosis Childhood Enuresis Growth Hormone Disorders Hyperparathyroidism Hyperthyroidism Guillain-Barre Syndrome Cytomegalovirus Fungal Infections Gram-Negative Cardiovascular Devices Prosthetic Heart Valve Peripheral Vascular Devices Cardiovascular Monitoring & Diagnostic Devices Cardiovascular Surgery Cardiac Rhythm Management Cardiovascular Prosthetic Devices Interventional Cardiology Cardiac Assist Devices Wound Care Management Hospital Supplies Syringes and Needles Disposable Hospital & Surgical Supplies Drug Delivery Devices Inhalation Systems Needle Free Injections Infusion Systems Diabetes Care Devices Insulin Delivery & Glucose Monitoring Ophthalmic Devices Cataract Surgery Devices Ophthalmic Diagnostic Equipment Refractive Surgery Devices ENT Devices Hearing Implants Diagnostic Devices Electrosurgical Devices Dental Equipment & Accessories Diagnostic Imaging & MRI Systems C/T Systems & Mammography Equipment X-Ray & Ultrasound Systems Nuclear Imaging Equipment Contrast Media Injectors Bone Densitometry Anesthesia and Respiratory Devices Anesthesia Machines & Disposables Respiratory Devices & Disposables Sleep Apnea Diagnostic Systems Healthcare IT Medical Imaging Information Systems Nephrology and Urology Devices Renal Dialysis Equipment Orthopedic Devices Orthobiologics & Arthroscopy Joint Reconstruction Trauma Fixation Orthopedic Prosthetics Cranium Maxillofacial Fixation (CMF) Spinal Surgery Endoscopy Devices & instruments Rigid & Flexible Endoscope In Vitro Diagnostics Genetic Testing Clinical Chemistry Hematology Immuno Chemistry MEDTECH & DIAGNOSTICS BIOPHARMACEUTICALS Value to the Company

Upload: scott-jordan

Post on 06-Aug-2015

45 views

Category:

Documents


5 download

TRANSCRIPT

Page 1: Value to  emerging growth companies

Diabetic NephropathyDiabetic RetinopathyHypercholesterolemiaOral MucositisGoutAcute Lymphocytic LeukemiaBone MetastasisBrain CancerBreast CancerCervical CancerChronic Lymphocytic LeukemiaEndometrial CancerEwing SarcomaGastric CancerGastrointestinal Stromal TumorsHead And Neck CancerHodgkin LymphomaKidney CancerLiver CancerMalignant MesotheliomaMedullary Thyroid CancerMelanomaMultiple MyelomaNon-Hodgkin LymphomaNon-Small Cell Lung CancerOvarian CancerPancreatic CancerTesticular CancerThyroid CancerAge Related Macular DegenerationKeratoconjunctivitis sicca (Dry Eye)Retinal Vein OcclusionAcute Respiratory Distress SyndromeSepsisStaphylococcal InfectionsAcute Coronary SyndromeAngina PectorisAtrial FibrillationCoronary Artery Disease (CAD)Critical Limb IschemiaHypertensionPulmonary Arterial HypertensionAcute PainAnxiety DisordersChronic PainDementiaDiabetic NeuropathyObsessive-Compulsive DisorderOsteoarthritis PainParkinson's DiseasePost-Traumatic Stress DisorderRestless Legs SyndromeSchizophreniaTraumatic Brain InjuryLiver CirrhosisChildhood EnuresisGrowth Hormone DisordersHyperparathyroidismHyperthyroidismGuillain-Barre SyndromeCytomegalovirusFungal InfectionsGram-Negative Bacterial InfectionsH1N1 InfectionHerpes ZosterHIV-1 InfectionHuman Papillomavirus InfectionsStaphylococcus Aureus (MRSA)

Cardiovascular Devices Prosthetic Heart Valve

Peripheral Vascular Devices Cardiovascular Monitoring & Diagnostic Devices

Cardiovascular Surgery Cardiac Rhythm Management

Cardiovascular Prosthetic Devices Interventional Cardiology

Cardiac Assist Devices Wound Care Management

Hospital Supplies Syringes and Needles

Disposable Hospital & Surgical Supplies Drug Delivery Devices

Inhalation Systems Needle Free Injections

Infusion Systems Diabetes Care Devices

Insulin Delivery & Glucose Monitoring Ophthalmic Devices

Cataract Surgery Devices Ophthalmic Diagnostic Equipment

Refractive Surgery Devices ENT Devices

Hearing Implants Diagnostic Devices

Electrosurgical Devices Dental Equipment & Accessories

Diagnostic Imaging & MRI Systems C/T Systems & Mammography Equipment

X-Ray & Ultrasound Systems Nuclear Imaging Equipment

Contrast Media InjectorsBone Densitometry

Anesthesia and Respiratory Devices Anesthesia Machines & Disposables

Respiratory Devices & DisposablesSleep Apnea Diagnostic Systems

Healthcare IT Medical Imaging Information Systems

Nephrology and Urology Devices Renal Dialysis Equipment

Orthopedic Devices Orthobiologics & Arthroscopy

Joint Reconstruction Trauma Fixation

Orthopedic Prosthetics Cranium Maxillofacial Fixation (CMF)

Spinal Surgery Endoscopy Devices & instruments

Rigid & Flexible Endoscope In Vitro Diagnostics

Genetic Testing Clinical Chemistry

Hematology Immuno Chemistry

Infectious Immunology Histology And Cytology

Patient Monitoring Multiparameter Patient Monitoring Micro-Electromechanical Systems

Non-invasive Blood Pressure Monitors Neurology Devices

Neurostimulation Devices Interventional Neurology

CSF Management Neurosurgical Products

Radiosurgery

ME

DT

EC

H

&

DI

AG

NO

ST

IC

S

BI

OP

HA

RM

AC

EU

TI

CA

LS

Value to the Company

Page 2: Value to  emerging growth companies

Healthcare’s Investment Marketplace

Dis

cove

ry

Dev

elop

-

men

t IND P

has

e I

Ph

ase

II

Ph

ase

III

NDA A

pp

rova

l

Lau

nch

Gro

wth

Mat

ure

Healthcare Development & Financing Cycle

IPO / Public MarketsVenture CapitalAngels / Founders Private Equity / M&A

SEE

D

EX

IT

… E M E R G I N G G R O W T H C O M PA N I E S

… ‘ L E A D ’ I N V E S T O R S

… D I R E C T I N V E S T O R S

… S T R AT E G I C PA R T N E R S & B U Y E R S

T R A N S F O R M I N G H E A LT H C A R E C A P I TA L M A R K E T S

on behalf of…

Page 3: Value to  emerging growth companies

Healthcare’s Investment Marketplace

HealthiosXchange

12,000 InvestorsAcross (10)

Asset Classes in (37) Countries &2,000 Strategics in(46) Market sectors

“Seed-to-Exit”Direct/Diversified

Investment

NO Adverse Selection

Messaging&

Notifications

Ratings & Reviews

Rules-BasedDeal Flow

Prediction & Sentiment Data

Proprietary Events

(6,000)+Growth

Companies

NO FeeNO Carry

Shorter “Exit”Horizons

Real-TimeValuations &

Research

Less Correlation

Reporting &Communications

ZeroUn-Invested

Capital

PREMIER POSITIONING

EXPANDED ACCESS TO CAPITAL

GREATER CERTAINTY

ESTABLISHED “EXIT” PATHWAY

SUPERIOR OUTCOMES

Page 4: Value to  emerging growth companies

Healthcare’s Investment Marketplace

Premiere Financing & Strategic Positioning

12,000 InvestorsAcross (10)

Asset Classes in (37) Countries &2,000 Strategics in(46) Market sectors

“Seed-to-Exit”Direct/Diversified

Investment

NO Adverse Selection

Messaging&

Notifications

Ratings & Reviews

Rules-BasedDeal Flow

Prediction & Sentiment Data

Proprietary Events

(6,000)+Growth

Companies

NO FeeNO Carry

Shorter “Exit”Horizons

Real-TimeValuations &

Research

Less Correlation

Reporting &Communications

ZeroUn-Invested

Capital

Page 5: Value to  emerging growth companies

Healthcare’s Investment Marketplace

Expanded Access to Capital

12,000 InvestorsAcross (10)

Asset Classes in (37) Countries &2,000 Strategics in(46) Market sectors

“Seed-to-Exit”Direct/Diversified

Investment

NO Adverse Selection

Messaging&

Notifications

Ratings & Reviews

Rules-BasedDeal Flow

Prediction & Sentiment Data

Proprietary Events

(6,000)+Growth

Companies

NO FeeNO Carry

Shorter “Exit”Horizons

Real-TimeValuations &

Research

Less Correlation

Reporting &Communications

ZeroUn-Invested

Capital

Page 6: Value to  emerging growth companies

Healthcare’s Investment Marketplace

Greater Transaction CertaintyRatings & Reviews Trending & Following

Matching & Targeting Geo-Location

Page 7: Value to  emerging growth companies

Healthcare’s Investment Marketplace

Established Financing & “Exit” Pathways

STRATEGIC PARTNERS & BUYERS

INSTITUTIONAL INVESTORS

Page 8: Value to  emerging growth companies

Healthcare’s Investment Marketplace

Superior Outcomes

SUPERIOR OUTCOMES

12,000 InvestorsAcross (10)

Asset Classes in (37) Countries &2,000 Strategics in(46) Market sectors

“Seed-to-Exit”Direct/Diversified

Investment

NO Adverse Selection

Messaging&

Notifications

Ratings & Reviews

Rules-BasedDeal Flow

Prediction & Sentiment Data

Proprietary Events

(6,000)+Growth

Companies

NO FeeNO Carry

Shorter “Exit”Horizons

Real-TimeValuations &

Research

Less Correlation

Reporting &Communications

ZeroUn-Invested

Capital